Published in Oncol Lett on August 01, 2014
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science (1998) 21.13
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet (2004) 11.37
Biology of gastrointestinal stromal tumors. J Clin Oncol (2004) 5.89
NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw (2010) 5.20
The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol (2005) 4.96
Gastrointestinal stromal tumours. Br J Surg (2003) 3.50
Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer (2008) 3.10
Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol (2001) 3.04
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. J Surg Oncol (2009) 2.88
Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol (2000) 2.63
Histopathology of gastrointestinal stromal tumor. J Surg Oncol (2011) 1.61
Local excision with adjuvant imatinib therapy for anorectal gastrointestinal stromal tumors. Tech Coloproctol (2013) 1.47
Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience. Ann Surg Oncol (2013) 1.28
Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectum. Int J Colorectal Dis (2013) 1.19
Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib. Ann Surg Oncol (2012) 1.16
The effect of neoadjuvant Imatinib therapy on outcome and survival after rectal gastrointestinal stromal tumour. Colorectal Dis (2011) 1.11
Neoadjuvant imatinib in gastrointestinal stromal tumor of the rectum: report of a case. Dis Colon Rectum (2005) 1.07
Clinical, pathologic, and immunohistochemical characteristics of gastrointestinal stromal tumors of the colon and rectum: implications for surgical management and adjuvant therapies. Dis Colon Rectum (2006) 1.05
Excision of mid-rectal lesions by the Kraske sacral approach. Br J Surg (1980) 1.04
The role of neoadjuvant imatinib mesylate therapy in sphincter-preserving procedures for anorectal gastrointestinal stromal tumor. Am J Clin Oncol (2011) 0.94
Surgical management of rectal gastrointestinal stromal tumors. J Surg Oncol (2012) 0.89
Local excision of rectal carcinoma not-exceeding the muscularis layer. Colorectal Dis (2003) 0.88
Transvaginal resection of a rectal gastrointestinal stromal tumor. Surg Today (2012) 0.83
Trans-sacral (Kraske) approach for gastrointestinal stromal tumour of the lower rectum: old procedure for a new disease. Colorectal Dis (2008) 0.81
The place of the posterior surgical approach for lesions of the rectum. Dig Surg (2005) 0.81
Transvaginal local excision of rectal carcinoma. Curr Surg (2004) 0.81
Transsacral approach to resect a gastrointestinal stromal tumor in the rectum: report of two cases. Surg Today (2007) 0.78
Malignant Rectal Gastrointestinal Stromal Tumour: Case Report and Review of Literature. J Gastrointest Cancer (2012) 0.77
Anorectal gastrointestinal stromal tumors: a retrospective multicenter analysis of 15 cases emphasizing their high local recurrence rate and the need for standardized therapeutic approach. Int J Colorectal Dis (2013) 0.77